Search results

1. Hospital Enterococcus faecium and Enterococcus faecalis with the vanB-mediated vancomycin resistance: epidemiology and b…

Principal investigator: prof. Ewa Olga Sadowy

Narodowy Instytut Leków

Call: OPUS 26, Panel: NZ2

2. Genomic analysis of invasive vancomycin-resistant Enterococcus faecium of VanA phenotype from intensive-care units in Po…

Principal investigator: dr Ewa Nina Wardal

Narodowy Instytut Leków

Call: SONATA 19, Panel: NZ7

3. Genomic epidemiology of Enterobacterales producing OXA-48-type carbapenemases in Poland, 2013-2023

Principal investigator: dr hab. Radosław Antoni Izdebski

Narodowy Instytut Leków

Call: OPUS 25, Panel: NZ2

4. CHIRAL RHENIUM AND RHODIUM COMPLEXES OF ANTICANCER AND ANTIBACTERIAL ACTIVITY: SYNTHESIS, ACTIVITY, AND PHYSICOCHEMICAL …

Principal investigator: prof. Jan Czesław Dobrowolski

Narodowy Instytut Leków

Call: OPUS 24, Panel: NZ7

5. Pharmacological potential of mistletoe (Viscum album L.) in the prevention of central nervous system disorders.

Principal investigator: Anna Szurpnicka

Narodowy Instytut Leków

Call: PRELUDIUM 20, Panel: NZ7

6. In search for molecular targets to overcome doxorubicin resistance in triple-negative breast cancer with the use of inno…

Principal investigator: Anna Karolina Pogorzelska

Narodowy Instytut Leków

Call: PRELUDIUM 20, Panel: NZ7

7. Influence of the route of administration of new psychoactive substances on their metabolic profile

Principal investigator: dr Magdalena Anna Popławska

Narodowy Instytut Leków

Call: SONATA 16, Panel: NZ7

8. Host sex effect on immunity and protection after oral immunization with Fasciola hepatica cysteine protease and the para…

Principal investigator: dr hab. Małgorzata Joanna Kęsik-Brodacka

Narodowy Instytut Leków

Call: OPUS 18, Panel: NZ6

9. Concomitant IDentification and Antibiotic REsistance profile of bacteria in one hour with an adaptive targeted single Ma…

Principal investigator: prof. Marek Tomasz Gniadkowski

Narodowy Instytut Leków

Call: JPIAMR2019, Panel: NZ6

10. Epidemic clonal lineages of Enterobacteriales producing VIM-type carbapenemases in Poland, 2006-19.

Principal investigator: dr hab. Radosław Antoni Izdebski

Narodowy Instytut Leków

Call: OPUS 17, Panel: NZ7

11. Yeast-based biosensors for the specific and accessible detection of pathogens and antimicrobial resistance

Principal investigator: dr Alicja Kuch

Narodowy Instytut Leków

Call: JPIAMR2019, Panel: NZ6

12. Studies of alkylation mechanism of DNA oligomers using new Top I inhibitors from camptothecin family by physical organic…

Principal investigator: prof. Lech Jan Kozerski

Narodowy Instytut Leków

Call: OPUS 14, Panel: ST4

13. Multidrug resistant Streptococcus pneumoniae invasive isolates of serotype 19A: a new epidemiological threat in Poland

Principal investigator: prof. Anna Skoczyńska

Narodowy Instytut Leków

Call: OPUS 11, Panel: NZ7

14. Epidemiology of metallo-beta-lactamase-producing multidrug-resistant Pseudomonas aeruginosa in Poland over the last deca…

Principal investigator: prof. Marek Tomasz Gniadkowski

Narodowy Instytut Leków

Call: OPUS 11, Panel: NZ7

15. The multilocus sequence typing (MLST) scheme for Pseudomonas putida and molecular epidemiology of metallo-beta-lactamase…

Principal investigator: Paweł Jakub Urbanowicz

Narodowy Instytut Leków

Call: PRELUDIUM 11, Panel: NZ7

16. Clonal structure and mobilome of glycopeptide resistant Enterococcus faecalis

Principal investigator: dr Ewa Nina Wardal

Narodowy Instytut Leków

Call: PRELUDIUM 8, Panel: NZ7

17. Characteristic of penicillin-resistant clinical isolates of Enterococcus faecalis

Principal investigator: Iwona Joanna Gawryszewska

Narodowy Instytut Leków

Call: PRELUDIUM 7, Panel: NZ7

18. Mechanistic study on enantioseparations of the novel oxazolidinones

Principal investigator: dr Katarzyna Irena Michalska

Narodowy Instytut Leków

Call: SONATA 6, Panel: NZ7

19. Inhibition of p21-Activated Kinase (PAK) as a new molecular target in the treatment of chronic myeloid leukemia (CML)

Principal investigator: dr hab. Sylwia Flis

Narodowy Instytut Leków

Call: OPUS 6, Panel: NZ7

20. Fentanyl opioid designer drugs: from molecular modeling to in vitro studies

Principal investigator: prof. Joanna Sadlej

Narodowy Instytut Leków

Call: OPUS 6, Panel: ST4

21. Streptococci from mitis group: defining the boundary between pathogenic Streptococcus pneumoniae and other commensal spe…

Principal investigator: dr hab. Ewa Olga Sadowy

Narodowy Instytut Leków

Call: HARMONIA 5, Panel: NZ2

22. IDENTIFICATION AND STRUCTURAL STUDIES OF NEW PSYCHOACTIVE SUBSTANCES IN SYNTHETIC NARCOTICS OF LAST GENERATION USING ORG…

Principal investigator: prof. Lech Jan Kozerski

Narodowy Instytut Leków

Call: OPUS 5, Panel: ST4

23. Streptococcus suis: molecular comparison of human and animal invasive strains

Principal investigator: dr hab. Ewa Olga Sadowy

Narodowy Instytut Leków

Call: OPUS 4, Panel: NZ2

24. Molecular epidemiology of carbapenemase-producing Enterobacteriaceae in Poland.

Principal investigator: prof. Marek Tomasz Gniadkowski

Narodowy Instytut Leków

Call: OPUS 4, Panel: NZ6

25. Structure of Neisseria meningitidis serogroup B population in Poland, 2010-2014.

Principal investigator: Izabela Joanna Waśko

Narodowy Instytut Leków

Call: PRELUDIUM 4, Panel: NZ7

26. The examination of isothiocyanates influence on cytotoxic and cytostatic effects of 5-fluorouracil in cancer cell lines …

Principal investigator: Małgorzata Milczarek

Narodowy Instytut Leków

Call: PRELUDIUM 3, Panel: NZ5

Projects search